0,922  0,002  GST A substrate
0,892  0,004  TNF expression inhibitor
0,890  0,004  Eye irritation, high
0,887  0,003  Skin irritative effect
0,885  0,006  Antiinflammatory
0,882  0,004  Platelet antagonist
0,869  0,004  Atherosclerosis treatment
0,861  0,004  Lipoprotein disorders treatment
0,846  0,004  Antidiabetic (type 2)
0,837  0,005  Antidiabetic
0,837  0,005  Cyclophilin D inhibitor
0,838  0,006  Caspase 9 stimulant
0,827  0,004  Cholesterol antagonist
0,823  0,004  NOS3 expression inhibitor
0,823  0,005  Antihypercholesterolemic
0,791  0,002  UGT2B1 substrate
0,786  0,003  Antimutagenic
0,775  0,008  Carcinogenic
0,743  0,004  Hypolipemic
0,730  0,002  GST P1-1 substrate
0,726  0,005  Hepatic disorders treatment
0,728  0,007  Antithrombotic
0,722  0,004  Apoptosis antagonist
0,716  0,005  UGT1A6 substrate
0,715  0,005  Vasodilator, peripheral
0,713  0,004  Antihypertriglyceridemic
0,700  0,007  UGT1A9 substrate
0,696  0,005  Cardioprotectant
0,702  0,012  CYP2C9 substrate
0,690  0,005  Angiogenesis stimulant
0,676  0,005  Platelet aggregation inhibitor
0,678  0,008  CTGF expression inhibitor
0,673  0,004  Platelet adhesion inhibitor
0,697  0,031  Apoptosis agonist
0,669  0,004  Diabetic retinopathy treatment
0,671  0,007  Caspase 3 stimulant
0,668  0,005  Antipruritic, allergic
0,671  0,011  Radioprotector
0,659  0,002  GABA C receptor agonist
0,658  0,005  Antiglaucomic
0,654  0,005  UDP-glucuronosyltransferase substrate
0,654  0,005  UGT1A4 substrate
0,644  0,005  Antidiabetic symptomatic
0,647  0,020  Teratogen
0,630  0,007  Hypoglycemic
0,614  0,005  Myocardial infarction treatment
0,614  0,005  Vasodilator
0,626  0,020  Embryotoxic
0,612  0,007  Metabolic disease treatment
0,614  0,013  Antiallergic
0,604  0,005  FMO1 substrate
0,601  0,003  UGT2B4 substrate
0,607  0,009  Antipsoriatic
0,610  0,012  Stroke treatment
0,605  0,013  Mutagenic
0,594  0,003  Antihyperlipoproteinemic
0,590  0,003  Vanilloid agonist
0,601  0,014  CYP2C19 substrate
0,584  0,005  Antiulcerative
0,604  0,031  Transcription factor NF kappa B inhibitor
0,581  0,013  Proliferative diseases treatment
0,568  0,007  Vascular (periferal) disease treatment
0,571  0,014  Immunomodulator
0,556  0,005  UGT1A3 substrate
0,547  0,005  Phospholipase C inhibitor
0,549  0,011  Antipyretic
0,541  0,004  GST M1-1 substrate
0,538  0,003  Succinate dehydrogenase inhibitor
0,539  0,005  Alpha-N-acetylglucosaminidase inhibitor
0,527  0,005  Non-steroidal antiinflammatory agent
0,525  0,004  UGT2B7 substrate
0,541  0,021  Bone diseases treatment
0,533  0,019  Histamine release inhibitor
0,542  0,029  Antiobesity
0,530  0,020  Chemoprotective
0,528  0,018  Ulceration
0,526  0,017  Antioxidant
0,522  0,016  Lipoxygenase inhibitor
0,527  0,026  Immunosuppressant
0,506  0,004  Abortion inducer
0,505  0,004  Protein kinase stimulant
0,504  0,005  VCAM1 expression inhibitor
0,501  0,008  Interleukin 2 agonist
0,507  0,013  Tumour necrosis factor alpha release inhibitor
0,495  0,004  Phospholipase A2 inhibitor
0,513  0,022  CYP1A2 substrate
0,511  0,023  Inflammatory Bowel disease treatment
0,500  0,012  ICAM1 expression inhibitor
0,532  0,046  Antiarthritic
0,488  0,002  Alcohol dehydrogenase substrate
0,502  0,018  NOS2 expression inhibitor
0,521  0,037  CYP3A4 substrate
0,485  0,004  Insulin sensitizer
0,482  0,003  Antipruritic, non-allergic
0,480  0,005  Aldehyde dehydrogenase inhibitor
0,486  0,011  UGT1A1 substrate
0,486  0,011  Antihypoxic
0,474  0,004  Tyrosine 3 hydroxylase inhibitor
0,477  0,008  Hair growth stimulant
0,471  0,005  5 Hydroxytryptamine uptake stimulant
0,495  0,030  Immunostimulant
0,467  0,004  Antieczematic
0,468  0,005  Urolithiasis treatment
0,484  0,023  AR expression inhibitor
0,481  0,024  Analeptic
0,461  0,005  Glutathione S-transferase substrate
0,481  0,026  Spasmolytic
0,462  0,008  Antiseptic
0,460  0,007  FMO3 substrate
0,455  0,003  Ferrochelatase inhibitor
0,477  0,028  Cytotoxic
0,482  0,035  Aldehyde oxidase inhibitor
0,452  0,007  Lipid peroxidase inhibitor
0,476  0,033  GABA C receptor rho-3 antagonist
0,449  0,006  Muscular dystrophy treatment
0,461  0,023  Cardiovascular analeptic
0,440  0,004  Porphobilinogen synthase inhibitor
0,462  0,026  Antiosteoporotic
0,444  0,011  Septic shock treatment
0,436  0,006  Acaricide
0,431  0,003  Adenylate kinase inhibitor
0,443  0,016  Radiosensitizer
0,431  0,005  Insulin secretagoues
0,456  0,031  Antifungal
0,439  0,014  Wound healing agent
0,459  0,034  Respiratory analeptic
0,426  0,002  Transcription factor NF kappa B stimulant
0,437  0,014  Interleukin agonist
0,421  0,004  Gastrin inhibitor
0,461  0,050  15-Lipoxygenase inhibitor
0,411  0,004  Antihelmintic (Nematodes)
0,413  0,014  Sodium/bile acid cotransporter inhibitor
0,403  0,005  Mediator release inhibitor
0,423  0,026  Chemopreventive
0,399  0,004  Peroxisome proliferator-activated receptor gamma agonist
0,397  0,002  UGT2B10 substrate
0,437  0,045  CYP2C19 inhibitor
0,396  0,004  Prostaglandin antagonist
0,448  0,058  Antibacterial
0,405  0,016  Flavin-containing monooxygenase substrate
0,404  0,015  Growth hormone agonist
0,393  0,005  Carcinogenic, group 1
0,442  0,055  5 Hydroxytryptamine release inhibitor
0,390  0,004  Arylamine N-Acetyltransferase substrate
0,407  0,021  DNA synthesis inhibitor
0,384  0,004  Prostaglandin EP2 antagonist
0,392  0,014  Hepatoprotectant
0,381  0,004  Antispirochetal
0,383  0,007  Acute respiratory distress syndrome (ARDS) treatment
0,415  0,040  CYP2D6 substrate
0,399  0,025  Antiparasitic
0,392  0,022  Peroxidase inhibitor
0,373  0,004  Catenin beta inhibitor
0,373  0,004  Glutamate dehydrogenase inhibitor
0,375  0,007  CYP2B6 inhibitor
0,405  0,038  Antiischemic
0,384  0,018  Anesthetic general
0,397  0,031  Interleukin antagonist
0,371  0,006  Cell adhesion inhibitor
0,368  0,005  Interleukin 4 antagonist
0,368  0,006  5-Lipoxygenase inhibitor
0,415  0,054  Toll-Like receptor agonist
0,403  0,045  5 Hydroxytryptamine release stimulant
0,383  0,028  Nitric oxide antagonist
0,396  0,042  Antihypertensive
0,359  0,010  Sepsis treatment
0,360  0,011  Protein-tyrosine phosphatase inhibitor
0,352  0,004  Alcohol oxidase inhibitor
0,360  0,013  Monophenol monooxygenase inhibitor
0,349  0,004  Triose-phosphate isomerase inhibitor
0,346  0,002  Aconitate hydratase inhibitor
0,364  0,021  Antihelmintic
0,352  0,009  Antidiabetic (type 1)
0,344  0,003  Prolactin inhibitor
0,345  0,003  Glycine transporter 2 inhibitor
0,342  0,004  Vanilloid 1 agonist
0,341  0,003  Prostaglandin F2 alpha antagonist
0,351  0,013  Bone formation stimulant
0,368  0,033  Superoxide dismutase inhibitor
0,336  0,003  Aldehyde dehydrogenase substrate
0,335  0,005  Catalase inhibitor
0,342  0,015  DNA methyltransferase I inhibitor
0,363  0,039  Sensitization
0,328  0,004  TRPA1 agonist
0,327  0,004  Phosphofructokinase-1 inhibitor
0,323  0,002  Lysophosphatidic acid 2 receptor antagonist
0,331  0,014  Genotoxic
0,321  0,005  Retinoprotector
0,320  0,005  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,318  0,004  Toll-Like receptor 2 antagonist
0,317  0,003  Glutamate decarboxylase inhibitor
0,344  0,035  Antineoplastic (liver cancer)
0,349  0,042  Antineoplastic (multiple myeloma)
0,306  0,003  Fumarate hydratase inhibitor
0,357  0,054  12-Lipoxygenase inhibitor
0,311  0,009  Cystathionine beta-synthase inhibitor
0,334  0,033  Antineoplastic (lymphocytic leukemia)
0,317  0,019  Carcinogenic, group 3
0,343  0,045  Antineurogenic pain
0,300  0,002  Prostaglandin agonist
0,319  0,023  DNA methylase inhibitor
0,308  0,013  Antipruritic
0,308  0,014  Corneal wound healing stimulator
0,367  0,075  Antiasthmatic
0,319  0,028  RNA-directed DNA polymerase inhibitor
0,319  0,029  Sedative
0,365  0,075  Toll-Like receptor 7 agonist
0,293  0,005  Coagulant
0,331  0,043  Free radical scavenger
0,295  0,007  Uterine stimulant
0,394  0,109  Antineoplastic (solid tumors)
0,297  0,013  Alkylator
0,287  0,004  Myasthenia Gravis treatment
0,294  0,011  Protein-tyrosine phosphatase 1B inhibitor
0,302  0,022  Antiacne
0,323  0,046  Insulysin inhibitor
0,299  0,022  Melanin inhibitor
0,296  0,020  Interferon gamma antagonist
0,286  0,012  DNA polymerase I inhibitor
0,276  0,003  Arachidonic acid antagonist
0,281  0,009  Excitatory amino acid transporter EAAC1 inhibitor
0,275  0,004  Leukotriene antagonist
0,284  0,013  Cholesterol synthesis inhibitor
0,271  0,002  Vanilloid 2 antagonist
0,292  0,023  Lipocortins synthesis antagonist
0,280  0,011  Cell wall synthesis inhibitor
0,286  0,019  UGT2B15 substrate
0,269  0,003  Restless leg syndrome treatment
0,312  0,048  Transcription factor STAT3 inhibitor
0,267  0,005  Carbamoyl phosphate synthetase inhibitor
0,274  0,011  Antianemic
0,310  0,050  Transcription factor STAT inhibitor
0,274  0,014  UGT2B9 substrate
0,260  0,004  Adenylate cyclase stimulant
0,306  0,050  Cytostatic
0,276  0,021  Antiparkinsonian, tremor relieving
0,276  0,022  Diabetic nephropathy treatment
0,258  0,004  CDC25A inhibitor
0,292  0,039  Antiparkinsonian, rigidity relieving
0,280  0,027  Thrombolytic
0,300  0,048  Acute neurologic disorders treatment
0,264  0,013  Neuropathy treatment
0,339  0,088  CYP2C9 inhibitor
0,257  0,008  Choleretic
0,255  0,006  Antirickettsial
0,261  0,014  SULT1A3 substrate
0,256  0,009  SULT1A1 substrate
0,250  0,005  Thioredoxin inhibitor
0,252  0,008  Antineoplastic, alkylator
0,245  0,003  Acyl-CoA dehydrogenase inhibitor
0,296  0,055  Antiprotozoal (Leishmania)
0,279  0,038  Antihypotensive
0,245  0,005  Potassium channel large-conductance Ca-activated activator
0,251  0,013  ATPase inhibitor
0,266  0,030  Neurotrophic factor enhancer
0,244  0,008  Potassium channel (Ca-activated) activator
0,240  0,007  Photosensitizer
0,299  0,069  Antineoplastic (pancreatic cancer)
0,240  0,011  Microtubule formation inhibitor
0,231  0,003  Thromboxane antagonist
0,233  0,006  Actinic keratosis treatment
0,229  0,003  UGT2B11 substrate
0,231  0,005  Leukotriene synthesis inhibitor
0,255  0,030  Diuretic
0,249  0,026  Skin whitener
0,230  0,007  Cell adhesion molecule inhibitor
0,230  0,008  AMP-activated protein kinase stimulant
0,250  0,029  Skeletal muscle relaxant
0,248  0,028  Amylase inhibitor
0,277  0,057  Antineoplastic (lymphoma)
0,224  0,006  Toll-Like receptor 2 agonist
0,223  0,004  GST T1-1 substrate
0,230  0,012  Antifungal (Cryptococcus)
0,232  0,015  Expectorant
0,223  0,006  Argininosuccinate synthase inhibitor
0,220  0,004  Peroxisome proliferator-activated receptor alpha agonist
0,224  0,009  GABA C receptor antagonist
0,222  0,009  Mucolytic
0,215  0,004  Glycine receptor agonist
0,230  0,019  Antineoplastic antimetabolite
0,213  0,003  Leukotriene B4 antagonist
0,251  0,041  P-glycoprotein inhibitor
0,246  0,037  Macular degeneration treatment
0,211  0,003  Ca2+-transporting ATPase inhibitor
0,211  0,003  Thromboxane A2 antagonist
0,277  0,071  Renal disease treatment
0,234  0,029  CNS active muscle relaxant
0,220  0,016  Antiviral (Poxvirus)
0,209  0,004  Acetyl-CoA transferase inhibitor
0,245  0,041  Antiviral (West Nile virus)
0,233  0,030  Cystic fibrosis treatment
0,235  0,031  Antiischemic, cerebral
0,207  0,003  Thromboxane synthase inhibitor
0,206  0,003  Antiviral (Parainfluenza)
0,222  0,019  Neurotrophic factor
0,210  0,008  Caspase 3 inhibitor
0,229  0,029  Antidote
0,205  0,004  Sphingosine 1-phosphate receptor 4 agonist
0,222  0,024  Antifungal enhancer
0,206  0,009  Sphingosine 1-phosphate receptor 5 antagonist
0,253  0,057  Psychostimulant
0,291  0,095  Vasodilator, coronary
0,198  0,002  Prostaglandin D2 agonist
0,203  0,007  Sphingosine 1-phosphate receptor 2 antagonist
0,204  0,008  Keratolytic
0,197  0,002  Lysophosphatidic acid 3 receptor antagonist
0,204  0,009  Antimetabolite
0,204  0,009  Folate antagonist
0,213  0,019  Aminopeptidase B inhibitor
0,240  0,047  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,204  0,013  Contraceptive female
0,195  0,005  Anabolic
0,190  0,003  Prostaglandin E2 agonist
0,191  0,005  Ornithine decarboxylase inhibitor
0,195  0,009  GABA C receptor rho-1 antagonist
0,189  0,004  Leukotriene D4 antagonist
0,190  0,006  Biliverdin reductase inhibitor
0,270  0,087  Antiepileptic
0,197  0,015  Hearing loss treatment
0,183  0,004  Endocannabinoid uptake inhibitor
0,203  0,025  Raynaud's phenomenon treatment
0,182  0,005  CDC25B inhibitor
0,182  0,006  Antifungal (Pneumocystis)
0,274  0,099  Antineoplastic (brain cancer)
0,172  0,002  Glucose-6-phosphate isomerase inhibitor
0,194  0,024  Farnesoid X receptor antagonist
0,203  0,033  Neurotensin receptor agonist
0,179  0,010  Toll-Like receptor 4 antagonist
0,175  0,008  Antidote, mercury
0,211  0,045  LDLR expression enhancer
0,200  0,036  Pancreatic disorders treatment
0,172  0,008  NAT1 substrate
0,165  0,003  Retinoid X alpha receptor agonist
0,176  0,016  Sphingosine 1-phosphate receptor 4 antagonist
0,175  0,015  Creatine kinase inhibitor
0,164  0,004  Kainate receptor antagonist
0,171  0,013  Electrolyte absorption antagonist
0,209  0,052  Muscle relaxant
0,180  0,023  Retinopathy treatment
0,158  0,002  G-protein-coupled receptor 120 agonist
0,170  0,015  Selectin antagonist
0,159  0,005  Oleamide hydrolase inhibitor
0,160  0,006  GABA aminotransferase inhibitor
0,170  0,017  Sphingomyelinase inhibitor
0,168  0,016  Alcohol dehydrogenase inhibitor
0,154  0,002  Leukotriene C antagonist
0,155  0,004  Glutamate (mGluR6) antagonist
0,191  0,041  Hexokinase inhibitor
0,186  0,038  GABA C receptor rho-2 antagonist
0,155  0,006  Glycine receptor antagonist
0,177  0,029  Cyclooxygenase 3 inhibitor
0,153  0,007  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,211  0,064  Pneumotoxic
0,154  0,009  Ornithine carbamoyltransferase inhibitor
0,269  0,125  Calcium channel activator
0,148  0,003  Vanilloid 4 agonist
0,145  0,002  Membrane dipeptidase inhibitor
0,190  0,047  Interleukin 6 antagonist
0,191  0,048  Antiviral (Hepatitis C)
0,237  0,095  Amyotrophic lateral sclerosis treatment
0,146  0,005  Sphingosine 1-phosphate receptor 5 agonist
0,144  0,003  Retinoid X receptor agonist
0,181  0,042  Hemostatic
0,163  0,024  Carbonic anhydrase III inhibitor
0,151  0,012  Aminopeptidase I inhibitor
0,165  0,025  NAT2 substrate
0,158  0,020  Calcium antagonist
0,149  0,012  Lanosterol 14 alpha demethylase inhibitor
0,211  0,075  Anticonvulsant
0,167  0,031  Growth stimulant
0,145  0,009  ATPase (Vacuolar H+) inhibitor
0,169  0,034  Cathepsin H inhibitor
0,179  0,045  Aldose reductase substrate
0,163  0,030  Menstruation disorders treatment
0,135  0,003  Prostacyclin agonist
0,138  0,007  Peroxisome proliferator-activated receptor gamma antagonist
0,140  0,009  NMDA receptor agonist
0,143  0,012  Ribonucleoside-diphosphate reductase inhibitor
0,159  0,030  Gastritis treatment
0,142  0,013  Phenylalanine 4-hydroxylase inhibitor
0,154  0,026  Antiviral (Influenza B)
0,139  0,011  Cannabinoid CB1 receptor agonist
0,139  0,012  Interferon agonist
0,129  0,002  Kainate receptor agonist
0,144  0,017  Paget's disease treatment
0,129  0,002  Leukotriene C4 antagonist
0,131  0,005  Phospholipase D inhibitor
0,145  0,019  NADH dehydrogenase inhibitor
0,148  0,022  Electron transport complex I inhibitor
0,128  0,003  Prostaglandin EP4 agonist
0,139  0,014  Ribonucleotide reductase inhibitor
0,174  0,050  Anesthetic
0,128  0,004  Peroxisome proliferator-activated receptor alpha antagonist
0,129  0,005  Prostaglandin EP3 antagonist
0,190  0,067  Antiviral (Hepatitis)
0,210  0,087  Peptidyltransferase inhibitor
0,132  0,013  Amidase inhibitor
0,174  0,054  Cyclooxygenase inhibitor
0,159  0,040  Antibacterial (Helicobacter pylori)
0,123  0,004  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,147  0,028  Gastric antisecretory
0,131  0,013  Bile acid receptor antagonist
0,122  0,004  Prostaglandin D2 antagonist
0,154  0,037  Heat shock protein 70 antagonist
0,166  0,049  Cyclooxygenase 1 inhibitor
0,121  0,004  Kainate receptor 2 antagonist
0,118  0,005  Peroxisome proliferator-activated receptor delta agonist
0,125  0,013  Hyperparathyroidism treatment
0,122  0,010  Anticholelithogenic
0,139  0,028  DOPA decarboxylase inhibitor
0,200  0,091  Cardiodepressant
0,117  0,008  GABA B receptor agonist
0,127  0,019  Glutathione S-transferase inhibitor
0,127  0,019  Antifungal (Candida)
0,131  0,023  Histidine decarboxylase inhibitor
0,176  0,068  Antineoplastic (bone cancer)
0,111  0,004  Acetyl-CoA transferase 1 inhibitor
0,110  0,004  Leukotriene B4 receptor 1 antagonist
0,114  0,008  Fatty acid synthase inhibitor
0,110  0,004  Prostaglandin EP4 antagonist
0,134  0,032  HIV-1 integrase (Overall Integration) inhibitor
0,137  0,034  UDP-glucose 4-epimerase inhibitor
0,103  0,003  Prostaglandin EP2 agonist
0,139  0,039  Antischistosomal
0,101  0,001  Prostaglandin F2 alpha agonist
0,102  0,002  Lysophosphatidic acid 1 receptor antagonist
0,099  0,002  Lysophosphatidic acid receptor 1 agonist
0,225  0,129  Antimycobacterial
0,212  0,116  Huntington's disease treatment
0,109  0,014  Antidote, heavy metal
0,125  0,031  Interleukin 1 beta converting enzyme inhibitor
0,114  0,020  Na+ K+ transporting ATPase inhibitor
0,097  0,004  Kainate receptor 1 antagonist
0,098  0,005  Prostacyclin antagonist
0,122  0,030  Tourette's syndrome treatment
0,138  0,046  Antiviral (Papilloma)
0,166  0,075  Aldehyde oxidase substrate
0,108  0,017  Estrogen-related receptor beta agonist
0,102  0,012  Antimycoplasmal
0,120  0,030  Topoisomerase II alpha inhibitor
0,097  0,006  Squalene synthetase inhibitor
0,129  0,039  Sulfotransferase substrate
0,143  0,053  Antihemorrhagic
0,191  0,102  Antiviral (HIV)
0,135  0,045  Gout treatment
0,148  0,058  Psychosexual dysfunction treatment
0,101  0,012  Interferon inducer
0,134  0,045  GABA receptor agonist
0,162  0,074  Prostate disorders treatment
0,153  0,065  Movement disorders treatment
0,107  0,020  SULT1A2 substrate
0,092  0,004  Pregnane X receptor antagonist
0,114  0,029  Cathepsin G inhibitor
0,113  0,028  Glutamate release inhibitor
0,105  0,020  Narcotic antagonist
0,154  0,070  Pulmonary hypertension treatment
0,113  0,029  Antibiotic
0,095  0,011  Antiviral (Herpesvirus 3, Human)
0,095  0,011  SULT2A1 substrate
0,150  0,067  Antiprotozoal (Coccidial)
0,084  0,004  ATP citrate lysase inhibitor
0,083  0,004  Glutamate (mGluR8) agonist
0,087  0,008  Anesthetic inhalation
0,127  0,048  Transcription factor STAT6 inhibitor
0,124  0,045  Neutropenia treatment
0,099  0,021  Elastase 1 inhibitor
0,097  0,019  Antidote, organophosphates
0,080  0,002  Thromboxane agonist
0,174  0,096  Growth factor agonist
0,113  0,036  Interleukin 12 antagonist
0,124  0,047  Antihelmintic (Fasciola)
0,078  0,002  Lysophosphatidic acid receptor 3 agonist
0,163  0,087  Phobic disorders treatment
0,080  0,005  GABA uptake inhibitor
0,120  0,045  Antiprotozoal (Toxoplasma)
0,102  0,027  Thioredoxin reductase inhibitor
0,091  0,017  Caspase 9 inhibitor
0,089  0,015  Nitric oxide donor
0,092  0,019  Purinergic P2X1 antagonist
0,088  0,016  Exportin-1 inhibitor
0,103  0,031  Granulocyte macrophage colony stimulating factor agonist
0,089  0,018  Gaucher disease treatment
0,157  0,086  Dual specificity phosphatase inhibitor
0,085  0,014  Plasminogen activator inhibitor antagonist
0,084  0,014  Sphingosine kinase inhibitor
0,075  0,004  Free fatty acid receptor 1 agonist
0,106  0,036  Carbonic anhydrase VI inhibitor
0,102  0,032  Antiviral (Hepatitis A)
0,149  0,079  Antiviral (Herpes)
0,098  0,029  Lipase inhibitor
0,110  0,042  Antineoplastic antibiotic
0,086  0,018  Prostaglandin E2 antagonist
0,086  0,018  Cannabinoid CB2 receptor antagonist
0,121  0,053  Chelator
0,090  0,024  Antitreponemal
0,070  0,004  Leukotriene B4 receptor 2 antagonist
0,101  0,035  Hematopoietic
0,102  0,037  Tocolytic
0,079  0,014  Lipocortins synthesis agonist
0,119  0,055  Carcinogenic, group 2B
0,068  0,004  Retinoid X receptor antagonist
0,099  0,035  Antiprotozoal activity enhancer
0,080  0,017  Sphingosine 1-phosphate receptor 3 antagonist
0,139  0,076  Pregnane X receptor agonist
0,081  0,018  MDM2 inhibitor
0,070  0,008  Arginase inhibitor
0,122  0,059  Interleukin 8 antagonist
0,070  0,008  Geranyltranstransferase inhibitor
0,066  0,004  GABA transporter 3 inhibitor
0,074  0,012  Adenosine deaminase inhibitor
0,289  0,228  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,084  0,023  Glutamate (mGluR7) antagonist
0,071  0,011  Mannosidase inhibitor
0,089  0,029  Glucagon-like peptide 1 agonist
0,141  0,082  NOS3 expression enhancer
0,061  0,002  Thromboxane A2 agonist
0,074  0,014  Alpha-mannosidase inhibitor
0,063  0,004  Vanilloid 3 antagonist
0,068  0,010  G protein-coupled receptor agonist
0,061  0,003  Prostaglandin H2 antagonist
0,073  0,015  Acetyl-CoA transferase 2 inhibitor
0,074  0,016  Sphingosine 1-phosphate receptor 1 antagonist
0,174  0,117  Cyclic AMP phosphodiesterase inhibitor
0,072  0,014  CD45 antagonist
0,174  0,117  Antiviral (Ebola)
0,171  0,114  VEGF expression inhibitor
0,061  0,005  HMG CoA reductase inhibitor
0,103  0,047  Phosphodiesterase 6D inhibitor
0,191  0,136  Neuropeptide Y2 antagonist
0,097  0,042  Antileprosy
0,138  0,083  Thiol protease inhibitor
0,057  0,002  Carbonic anhydrase VIII inhibitor
0,057  0,002  Carbonic anhydrase X inhibitor
0,069  0,015  HCV NS3/NS4A protease inhibitor
0,172  0,119  Fibrosis treatment
0,075  0,023  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,059  0,007  Sodium-dependent vitamin C transporter 2 inhibitor
0,056  0,004  Retinoid X alpha receptor antagonist
0,093  0,041  Carbonic anhydrase XIII inhibitor
0,080  0,028  NMDA receptor glycine site agonist
0,063  0,011  Sphingosine 1-phosphate receptor 1 agonist
0,078  0,028  Uterine relaxant
0,078  0,028  Cannabinoid CB1 receptor antagonist
0,185  0,135  Antineoplastic (ovarian cancer)
0,117  0,068  Proteasome inhibitor
0,085  0,036  Sphingosine 1-phosphate receptor antagonist
0,062  0,013  AICAR transformylase inhibitor
0,070  0,021  Sphingosine kinase 2 inhibitor
0,063  0,015  Sphingosine 1-phosphate receptor agonist
0,052  0,004  Calcium-independent phospholipase A2 inhibitor
0,054  0,007  Lysine carboxypeptidase inhibitor
0,110  0,063  Nav1.4 sodium channel blocker
0,180  0,134  DNA damaging
0,075  0,028  Carbonic anhydrase stimulant
0,115  0,069  Shock treatment
0,165  0,119  Histone acetyltransferase inhibitor
0,053  0,007  Glutamate (mGluR8) antagonist
0,061  0,015  5-Alpha-reductase inhibitor
0,091  0,046  mTOR complex 2 inhibitor
0,169  0,124  Antiamyloidogenic
0,054  0,010  Glutamate (mGluR3) antagonist
0,049  0,005  Glutamate (mGluR3) agonist
0,083  0,039  Epoxide hydrolase inhibitor
0,056  0,012  Nicotinic acid receptor agonist
0,075  0,032  Antiemphysemic
0,059  0,016  Microtubule stabilization
0,047  0,005  Elastase 3A inhibitor
0,047  0,005  Elastase 2B inhibitor
0,047  0,005  Elastase 3B inhibitor
0,121  0,079  Cyclooxygenase 2 inhibitor
0,050  0,008  Integrin alpha1beta1 antagonist
0,081  0,039  Cannabinoid receptor antagonist
0,054  0,013  Inosine monophosphate dehydrogenase inhibitor
0,054  0,013  AMPA 4 receptor antagonist
0,043  0,003  Retinoid X beta receptor antagonist
0,058  0,018  Thymidylate synthase inhibitor
0,056  0,016  Glutamate (mGluR4) antagonist
0,064  0,026  GP IIb/IIIa receptor antagonist
0,053  0,014  Factor XIIIa inhibitor
0,064  0,026  Autotaxin inhibitor
0,060  0,023  Heparanase inhibitor
0,064  0,027  Ryanodine receptor antagonist
0,070  0,033  TRPA1 antagonist
0,086  0,049  Antiviral (Dengue virus)
0,051  0,014  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,098  0,062  Xanthine oxidase inhibitor
0,067  0,031  Maillard reaction inhibitor
0,175  0,140  Nitric-oxide synthase stimulant
0,058  0,023  Squalene epoxidase inhibitor
0,180  0,146  Antituberculosic
0,044  0,010  GABA transporter 2 inhibitor
0,110  0,075  Sphingosine 1-phosphate receptor 2 agonist
0,110  0,076  Adenylate cyclase inhibitor
0,045  0,012  Free fatty acid receptor 1 antagonist
0,049  0,017  Sphingosine kinase 1 inhibitor
0,055  0,023  Cholesterol esterase inhibitor
0,122  0,089  Histone deacetylase SIRT1 inhibitor
0,036  0,005  Vanilloid 2 agonist
0,041  0,009  Kynurenine 3 monooxygenase inhibitor
0,093  0,062  Antiviral (Rhinovirus)
0,034  0,003  Vitamin D receptor agonist
0,045  0,015  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,076  0,046  Potassium channel (Tandem pore domain) blocker
0,036  0,006  Retinoid X gamma receptor antagonist
0,037  0,008  Retinoid X gamma receptor agonist
0,036  0,007  Glutamate (mGluR1a) agonist
0,044  0,015  VCAM-1 antagonist
0,044  0,015  VCAM antagonist
0,117  0,089  Antihelmintic (Trematoda)
0,132  0,105  Prostatic (benign) hyperplasia treatment
0,048  0,021  Angiotensin AT1 receptor antagonist
0,049  0,022  Glutamate (mGluR group III) antagonist
0,111  0,085  Antiprotozoal (Amoeba)
0,045  0,018  Farnesoid X receptor agonist
0,049  0,022  Guanylate cyclase inhibitor
0,045  0,019  Cholecystokinin B agonist
0,093  0,068  Anticataract
0,066  0,042  Protease 3C (Human rhinovirus) inhibitor
0,058  0,033  Adenine nucleotide translocase inhibitor
0,030  0,005  GABA transporter inhibitor
0,033  0,008  Glutamate (mGluR1) agonist
0,038  0,014  Carboxypeptidase B inhibitor
0,067  0,043  Cannabinoid receptor agonist
0,094  0,070  Nitric-oxide synthase inhibitor
0,144  0,121  Antiarrhythmic
0,045  0,022  Leukotriene A4 hydrolase inhibitor
0,043  0,021  Cholesterol absorption inhibitor
0,049  0,027  Purinergic P2Y antagonist
0,082  0,061  Carcinogenic, group 2A
0,027  0,005  N-Acetylated alpha-linked acidic dipeptidase inhibitor
0,031  0,010  Excitatory amino acid transporter 2 inhibitor
0,030  0,008  Retinoid X beta receptor agonist
0,083  0,061  D-Ala-D-Ala ligase inhibitor
0,089  0,068  ABCA1 expression enhancer
0,038  0,017  Peroxisome proliferator-activated receptor delta antagonist
0,042  0,022  Histone deacetylase 7 inhibitor
0,030  0,010  Prostaglandin EP1 antagonist
0,025  0,004  Calcium-dependent phospholipase A2 inhibitor
0,028  0,007  Isoleucine-tRNA ligase inhibitor
0,040  0,020  Calcitonin receptor agonist
0,024  0,004  Glutamate (mGluR6) agonist
0,034  0,015  Uridine phosphorylase inhibitor
0,057  0,038  Carbonic anhydrase VB inhibitor
0,026  0,007  Excitatory amino acid transporter 3 inhibitor
0,162  0,143  Antineoplastic (renal cancer)
0,031  0,012  Nicotinic acid receptor 2 antagonist
0,043  0,024  Dopamine D5 agonist
0,023  0,005  Methylmalonyl-CoA mutase inhibitor
0,039  0,020  Phosphoglycerate kinase inhibitor
0,096  0,078  Factor V inhibitor
0,054  0,036  Nicotinic alpha3beta2 receptor antagonist
0,030  0,012  Purinergic P2Y12 antagonist
0,055  0,037  Angiotensin-converting enzyme inhibitor
0,035  0,017  Peptide deformylase inhibitor
0,179  0,162  Prostate cancer treatment
0,025  0,008  Aminopeptidase A inhibitor
0,030  0,013  Thyroid hormone agonist
0,025  0,008  Neuraminidase (Influenza B) inhibitor
0,060  0,044  NMDA 2C receptor antagonist
0,051  0,035  Prolyl endopeptidase inhibitor
0,035  0,019  Caspase 2 inhibitor
0,036  0,021  Angiotensin II receptor antagonist
0,019  0,004  Carbonic anhydrase XI inhibitor
0,040  0,026  Dihydropteroate synthase inhibitor
0,066  0,051  Carbonic anhydrase VA inhibitor
0,019  0,005  GABA transporter 1 inhibitor
0,024  0,011  5-Alpha-reductase 2 inhibitor
0,043  0,030  Macrophage elastase inhibitor
0,055  0,042  Postcoital contraceptive
0,048  0,035  Bombesin 2 receptor antagonist
0,043  0,030  Integrin antagonist
0,022  0,010  Caspase 8 inhibitor
0,025  0,012  Monocarboxylic acid transporter 1 inhibitor
0,025  0,012  Monocarboxylic acid transporter inhibitor
0,016  0,004  Calcineurin inhibitor
0,039  0,028  Glucagon-like peptide 1 receptor antagonist
0,091  0,080  Glutamate (mGluR7) agonist
0,031  0,020  Epoxide hydrolase 1 inhibitor
0,113  0,102  Papain-like protease (SARS coronavirus) inhibitor
0,019  0,009  Telomerase stimulant
0,020  0,009  Ileal bile acid transport inhibitor
0,042  0,032  GABA B receptor antagonist
0,048  0,039  Diacylglycerol O-acyltransferase inhibitor
0,038  0,029  Retinoic acid alpha receptor agonist
0,027  0,017  Toll-Like receptor 4 agonist
0,053  0,043  Dihydroorotate oxidase inhibitor
0,013  0,004  Folate transporter 1 inhibitor
0,023  0,014  Integrin alphaVbeta3 antagonist
0,027  0,019  Hedgehog signaling activator
0,028  0,019  LFA antagonist
0,041  0,032  Leukocyte elastase inhibitor
0,038  0,030  Histone deacetylase 9 inhibitor
0,052  0,044  Glucosylceramidase inhibitor
0,014  0,006  Immunosuppressant Cyclosporine-like
0,120  0,112  Anticoagulant
0,093  0,085  Antiinfertility, female
0,029  0,021  AMPA 3 receptor antagonist
0,040  0,032  Oxytocin agonist
0,028  0,021  1,3-Beta-glucan synthase inhibitor
0,028  0,021  Purinergic P2Y15 antagonist
0,018  0,012  5-Alpha-reductase 1 inhibitor
0,015  0,009  Integrin beta6 antagonist
0,032  0,026  Sphingosine 1-phosphate receptor 3 agonist
0,029  0,024  Histone deacetylase 11 inhibitor
0,029  0,024  Histone deacetylase class IV inhibitor
0,022  0,017  ICAM 1 antagonist
0,026  0,021  Hypoxanthine phosphoribosyltransferase inhibitor
0,098  0,093  Acetylcholine release stimulant
0,030  0,026  Methionyl aminopeptidase 1 inhibitor
0,181  0,177  Hypoxia-inducible factor 1 alpha inhibitor
0,090  0,086  HDL-cholesterol increasing
0,141  0,138  Toxic, respiratory center
0,015  0,012  Thyroid hormone alpha antagonist
0,075  0,072  Antineoplastic alkaloid
0,026  0,024  Glucagon receptor antagonist
0,039  0,036  NMDA receptor subunit 3B antagonist
0,007  0,005  Phosphoribosylglycinamide formyltransferase inhibitor
0,021  0,018  GRP78 expression inhibitor
0,021  0,019  Retinoic acid gamma receptor agonist
0,050  0,048  DNA helicase inhibitor
0,035  0,033  Urate transporter 1 inhibitor
0,086  0,083  Topoisomerase I inhibitor
0,024  0,022  Urotensin II agonist
0,016  0,014  Vesicular glutamate transport inhibitor
0,073  0,071  ErbB-3 antagonist
0,045  0,044  Aldose reductase inhibitor
0,037  0,035  Thymidine kinase inhibitor
0,058  0,056  Carbonic anhydrase V inhibitor
0,006  0,005  Integrin alpha5beta6 antagonist
0,092  0,091  Anesthetic local
0,041  0,040  Glycine transporter inhibitor
0,066  0,065  NAD(P)H dehydrogenase (quinone) inhibitor
0,018  0,017  Retinoic acid beta receptor agonist
0,032  0,032  Ceramide glucosyltransferase inhibitor
0,012  0,012  Angiotensin AT1B receptor antagonist
0,032  0,032  NMDA receptor subunit 3A antagonist
0,104  0,104  Allergic rhinitis treatment

